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Purpose: Routine physical examination is recommended in follow up guidelines for women
with a history of breast cancer. The objective of this paper is to assess the contribution of
routine physical examination in addition to mammography in the early diagnosis of breast
cancer recurrences.
Patients and methods: The medical follow-up documents of 669 patients were reviewed. 127
contra-lateral breast cancers (CBCs) and 58 loco-regional recurrences (LRRs) in 163 patients
were included. The additional contribution of routine physical examination over mammog-
raphy was evaluated with the proportions of CBCs or LRRs detected by physical examina-
tion alone. v2 tests were used to compare the difference of contribution of physical
examination among subgroups.
Results: Seven (6%) out of 127 CBCs and 13 (22%) out of 58 LRRs were detected by routine
physical examination alone. Six LRRs (17%; 6/35) were in patients after breast conserving
surgery and seven LRRs (30%; 7/23) in patients after mastectomy. There was a trend that
the contribution of physical examination is higher in women under 60 years of age in
the detection of CBCs (9%; 5/57) and LRRs (28%, 8/29) than in women over 60 years of age
(CBCs:3%; 2/70 and LRRs:17%, 5/29; v2 = 3.090, P = 0.079).
Conclusions: Twenty-two percent of loco regional breast cancer recurrences would have
been detected later without physical examination. Routine physical examination may be
most valuable for women with a history of breast cancer younger than 60 years at fol-
low-up visit.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
A combination of high incidence and good survival makes
breast cancer the most prevalent cancer in women.1 This putser Ltd. All rights reserved
fax: +31 503614873.
. Jansen).an increasing burden on follow-up oncology clinics. It is pre-
dicted that there will be a 48% increased need for cancer ser-
vices by 2020.2 Specialists are facing an ever-increasing
workload of providing long-term follow-up care for women.
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guidelines and programmes to provide comprehensive, com-
passionate and cost-effective follow-up care.3
One of the main purposes of follow-up after breast cancer
is early detection of isolated breast cancer recurrences such
as loco-regional recurrence (LRR) and contra-lateral breast
cancer (CBC), because these are the kind of recurrences that
could be treated aiming at cure or long term disease free sur-
vival. A meta-analysis suggested that early detection of
isolated breast cancer recurrences is associated with an in-
creased chance of survival.4 Routine mammography and
physical examination are recommended in the follow up
guidelines for women with a history of breast cancer to detect
these LRRs and CBCs early.5–7 The value of mammography for
early detection of CBC has been confirmed in several stud-
ies.8–10 In addition, LRR in the conserved breast can often be
detected early by mammography.11,12 However, the contribu-
tion of routine physical examination to the early detection
of a recurrence is debatable and estimates for the proportion
of recurrences detected by physical examination alone vary
from 6% to 40%.13 It is known that the performance of
physical examination is at least influenced by age and
previous surgical treatment (breast conserving surgery versus
mastectomy).14,15 In addition, a higher frequency physical
examination in the first 5 year after primary treatment has
been recommended.16 It was hypothesised that there might
be more LRRs and CBCs detected by routine physical exami-
nation due to the intensive follow-up in the first 5 years after
primary treatment. The aim of the current study is to evaluate
the contribution of physical examination in addition to mam-
mography during following up of women with a history of
breast cancer, and to assess the influence of patient’s age at
follow-up visit, previous surgical treatment and the time
since primary diagnosis on the diagnostic value of physical
examination.
2. Patients and methods
2.1. Settings and subjects
Patients with breast cancer were selected from the files of the
regional cancer registry of the former Comprehensive Cancer
Centre North-Netherlands (CCCN, merged into the Compre-
hensive Cancer Centre Northeast-Netherlands in 2009). This
cancer registry contains data on diagnosis, stage and treat-
ment actively abstracted from the medical records of all hos-
pitals within the CCCN catchment area using a national
registration and coding manual of the Dutch Association of
Comprehensive Cancer Centres.
For 5589 consecutive women, breast cancer was the first
primary cancer diagnosed in four hospitals in the Northern
part of the Netherlands (an academic hospital, a large teach-
ing hospital and two non-teaching hospitals) from January
1989 to January 2003. A new primary tumour was defined as
any new tumour that was not a recurrence or direct extension
of the known tumour. All these women were without
evidence of distant metastasis at the moment of primary
diagnosis. Of these 5589 women a total of 139 patients devel-
oped CBC at least six months after the first tumour and those
CBCs were registered in the database. Because the informa-tion on follow-up and LRRs is not available in the cancer reg-
istry, this additional follow-up information was retrieved
from the medical documents in the four participating hospi-
tals. Follow-up information was collected for all 139 patients
with a CBC and for a sample of the patients (n = 597) without
a CBC. To minimise bias, patients without a CBC were strati-
fied on hospital of diagnosis, age at first primary tumour
and duration of follow-up before sampling.
For these 736 patients, follow-up information was re-
trieved from medical documents in the four participating
hospitals (Fig. 1). Follow up documents were unavailable for
67 patients (9%) of whom 12 patients had CBCs. Of the
remaining 669 women included in this cohort, 51 patients
were found to have developed a total of 58 LRRs (recurrences
in the conserved breast, chest wall, axilla or supraclavicular
nodes at the same side of the primary tumour). Recurrences
that were detected in the same patient within a six months
period were considered as one recurrence.
Therefore, a total of 127 CBCs and 58 LRRs in 163 patients
were reported in this cohort. In the other 506 patients there
was no evidence of LRRs or CBCs. Patients who developed dis-
tant metastases before or at the time of CBC or LRR were not
included.
2.2. Data abstraction
For all patients included in our study cohort, the information
regarding appointments and tests were retrieved, including
date of appointment, symptoms reported by the patients dur-
ing or pending the appointment (yes or no; and kind of symp-
toms if applicable), findings of routine physical examination
(mass, abnormality in scar, abnormality in axilla or supra-cla-
vicular) and mammography. For these analyses, all follow-up
visits were regrouped into episodes, which were defined as
45-d periods. It was assumed that follow-up appointments
that happened within these episodes were related to each
other, so the information was combined.
2.3. Definitions
Routine physical examination was defined as the physical
examination undertaken by a physician during the routine
follow-up visits with or without mammography. Routine
mammography was defined as a mammography that was
undertaken during routine follow-up visits with or without
physical breast examination.
The mode of detection of CBCs and LRRs was classified as
mammography alone (in case of normal findings on physical
examination and abnormal mammograms in asymptomatic
patients); physical examination alone (in case of abnormal
findings on physical examination and normal mammograms
in asymptomatic patients); both mammography and physical
examination (in case of abnormal findings of physical exam-
ination and abnormal mammograms in asymptomatic pa-
tients) and symptoms (reported by patients at interval visits
between two scheduled follow-up visits or presented at
scheduled follow-up visits).
The contribution of routine physical examination was
evaluated by assessing the proportion of recurrences detected
by routine physical examination alone. The analysis of the
* MCBC : Metachronous contra-lateral breast cancer
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Fig. 1 – Graphical illustration of the sampling of study cohort.
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ber of recurrences.
2.4. Statistical analysis
Comparisons of the contribution of physical examination
were performed by v2 tests among subgroups with respect
to the type of recurrences, the surgical treatment of the first
tumour, age of the patient at the time of recurrence and the
time from the first tumour. For all the patients included in
this sample, the information on follow-up and LRR was col-
lected from the documents in hospital including the follow-
up appointments and the follow-up procedures. The number
of mammographies and physical examinations performed
during the follow-up of each patient was analysed aiming to
give a profile of the burden of follow-up in case of a LRR. Be-
cause CBC events were oversampled, the burden of follow-up
to detect CBCs early could not be assessed. The number of
routine physical examinations undertaken for the early
detection of one additional loco-regional recurrence in addi-
tion to routine mammography was calculated in subgroups
with respect to surgical treatment modality, patients’ age
and the time from the first tumour.
3. Results
3.1. Characteristics of patients and the primary breast
cancer
Of the 669 included patients, 56% (n = 375) were younger than
60 years of age when the primary breast cancer was diag-
nosed (Table 1). 32% (n = 214) of patients received breast con-
serving surgery as primary treatment, 57% (n = 383) of thepatients received radiotherapy, 15% (n = 101) chemotherapy
and 21% (n = 139) hormonal therapy, respectively. The median
follow-up time was 11.0 years (1.6–18.1).
3.2. Characteristics of CBCs and LRRs
Out of 127 CBCs, 45% (n = 57) were diagnosed in patients un-
der the age of 60 (Table 1). Seventy-five percent (n = 84) out
of 112 CBCs with specified pathological T stage were detected
at stage T1 or Tis. Of all CBCs, 70% (80/114) were detected
without lymph nodes involved. 31% (n = 39) of 127 patients
with CBC received radiotherapy for the CBC, 13% (n = 16) re-
ceived chemotherapy and 26% (33) received hormonal ther-
apy. Thirty-four percent of CBCs (n = 43) were diagnosed
more than 5 years after primary treatment.
Out of the 58 isolated LRRs, 50% (29) were diagnosed in pa-
tients under the age of 60 (Table 1). Forty-nine percent of the
LRRs (n = 25) were treated with mastectomy, where 51% of
LRRs (n = 26) were treated with local excision. Five LRRs were
detected in women who had breast conserving surgery previ-
ously and 21 LRRs were detected in women who had mastec-
tomy previously. For seven LRRs the type of surgical treatment
was unknown.
For 34% of LRRs (n = 20), patients received radiotherapy, for
85% of LRRs (n = 49), patients received chemotherapy and for
33% of LRRs (n = 19) patients received hormonal therapy.
Thirty-one (53%) out of 58 LRRs developed more than 5 years
after the primary treatment.
3.3. Detection of contra-lateral breast cancers
Of 127 CBCs, seven (6%) were detected by routine physical
examination alone, 42 (33%) were detected by mammography
Table 1 – Characteristics of patients and their tumoursa n (%).
Characteristics Primary tumour N = 669 CBC N = 127 LRR N = 58
Age group at diagnosis
<60 375 (56) 57 (45) 29 (50)
60+ 294 (44) 70 (55) 29 (50)
Pathologic T stage
pTis 57 (9) 14 (12) –
pT1 321 (49) 70 (63) –
pT2/3/4 281 (42) 28 (25) –
Unknown 10 15 –
Pathologic N stage
N0 439 (67) 80 (70) –
N+ 215 (33) 34 (30) –
Unknown 15 13
Surgery
Lumpectomy/local excision 214 (33) 35 (34) 26 (51)
Mastectomy 429 (67) 68 (66) 25 (49)
Unknown 26 24 7
Radiation therapy
Yes 383 (57) 39 (31) 20 (34)
No 286 (43) 88 (69) 38 (66)
Chemotherapy
Yes 101 (15) 16 (13) 49 (85)
No 568 (85) 111 (87) 9 (15)
Hormonal therapy
Yes 139 (21) 33 (26) 19 (33)
No 530 (79) 94 (74) 39 (67)
Time of follow up (median (range) years) 11.0 (1.6-18.1) 10.0 (1.6–18.1) 11.6 (2.2–17.5)
Time from first tumour (years) – 3.8 (0.6–11.9) 5.0 (0.6–15.6)
<5 years – 84 (66) 27 (47)
5 years or more – 43 (34) 31 (53)
a Recurrences-based analysis.
Table 2 – Contribution of physical examination to mammography in follow-up of patients with breast cancera n(%).
Method of detection CBC (n = 127) LRR_BCSb (n = 35) LRR_Mastectomyc (n = 23)
Routine physical examination alone 7 (6) 6 (17) 7 (30)
Routine mammography alone 42 (33) 7 (20) –
Both 26 (20) 11 (31) –
Symptoms reported by patients 52 (41) 11 (31) 16(70)
a Recurrences-based analysis.
b LRR_BCS: Loco regional recurrence in patients after breast conserving surgery.
c LRR_Mastectomy: LRR in patients after mastectomy.
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ties (Table 2). Of the 75 asymptomatic patients with CBCs,
33 (44%; 95%CI: 32–56%) were palpable by the physician at rou-
tine follow-up visits. Out of 52 patients (41%) who reported
symptoms leading to the diagnosis of a CBC, 11 (9%) pre-
sented at scheduled follow-up visits and 41 (32%) presented
as interval cases.
In total, 86 patients (67.7%) with CBCs were detected dur-
ing routine follow-up visits and 41 (33.3%) presented as inter-
val cases. Out of 86 patients detected during routine follow-up
visits, 33 patients (38.4%) with CBCs were palpable in routine
physical examinations.3.4. Detection of loco-regional recurrences
In 214 patients who received breast conserving surgery for the
primary tumour, 16% (n = 35) of LRRs were diagnosed. Eleven
LRRs after BCS were diagnosed because of symptoms reported
by the patient (31%) between two scheduled follow-up visits
and none at the moment of a scheduled visit. Of the 24
asymptomatic LRRs, 17 (71%; 95%CI: 51–91%) were palpable
by the physician at routine follow-up visits. Six of the LRRs
(17%) were diagnosed by routine physical examination alone,
20% (n = 7) by routine mammography alone and 31% (n = 11)
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Fig. 2 – Number of routine physical examinations performed to detect one additional LRR.
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LRRs were diagnosed. Of these, 30% (n = 7) were detected by
routine physical examination alone (Table 2). Seventy percent
(n = 16) presented with symptoms in which 40% (n = 9) pre-
sented at scheduled follow-up visits and 30% (n = 7) presented
as interval cases.
In total, 40 patients (69.0%) with LRRs were detected during
routine follow-up visits and 18 (31.0%) presented as interval
cases. Out of 40 patients detected during routine follow-up
visits, 24 patients (60.0%) with LRRs were palpable in routine
physical examinations.
When considering only the first recurrence in each patient,
it was found that seven (6%) out of 120 CBCs and six (14.0%)
out of 43 LRRs (four LRRs after breast conserving surgery
and two LRRs after mastectomy) were detected by routine
physical examination alone.
3.5. Contribution of physical examination
Seven (6%) out of 127 CBCs and 13 (22%) out of 58 LRRs in
which six LRRs (17%; 6/35) in patients after breast conserving
surgery and seven LRRs (30%; 7/23) in patients after mastec-
tomy were detected by routine physical examination alone.
The incremental contribution of physical examination was
higher in detecting LRRs than in detecting CBCs (v2 = 11.797,
P = 0.001).
Seventeen percent (n = 6) of 35 LRRs after breast conserv-
ing surgery and 30% (n = 7) of 23 LRRs after mastectomy would
have been detected later, if there was no routine physical
examination. The difference in the contribution of physical
examination in the detection of LRRs after BCT or after mas-
tectomy was not statistically significant (v2 = 1.410, P = 0.235).
There was a trend that the proportion of recurrences de-
tected by physical examination alone was higher in women
under 60 years of age at follow-up visit than in those over
60 years (v2 = 3.090, P = 0.079). In women under 60 years of
age at follow-up visit, 9% (n = 5) of 57 CBCs and 28% (n = 8)
of 29 LRRs would have been missed, if there was no routine
physical examination. For women over 60, 3% (n = 2) of 70
CBCs and 17% (n = 5) of 29 LRRs would have been detected la-
ter if there was no routine physical examination, respectively.Of the recurrences occurring within 5 years after the pri-
mary tumour, 4% (n = 3) of 84 CBCs and 26% (n = 7) of 27 LRRs
were detected with routine physical examination alone. For
recurrences occurring after 5 years from the first tumour, 9%
(n = 4) of 43 CBCs and 19% (n = 6) of 31 LRRs were detected
with routine physical examination. There is no significant
association between the proportions of recurrences detected
by physical examination alone and time from the first tumour
(v2 = 0.934, P = 0.334).
Eight hundred and one (10,411/13) physical examinations
were done to detect one additional LRR. In patients after
breast conserving surgery, 716 (4298/6) physical examinations
were done to detect one additional LRR. In patients after mas-
tectomy, 873 (6113/7) physical examinations were done to de-
tect one additional LRR. For patients younger than 60 years,
644 (5152/8) physical examinations were done to detect one
additional LRR, whereas the number was 1052 (5259/5) for pa-
tients older than 60. In the first 5 years, 1041 (7286/7) physical
examinations were done to detect one additional LRR,
whereas this number was 521 (3125/6) more than 5 years after
primary treatment (Fig. 2).
4. Discussion
If there was no routine physical examination, 22% of 58 LRRs
and 6% of 127 CBCs would have been detected later. There
was a trend towards a higher contribution of physical exam-
ination in detecting LRR in younger (<60) patients than in old-
er (P60) patients. For patients younger than 60 years at
follow-up visit, 644 physical examinations were performed
to detect one additional LRR, whereas, for patients older than
60 years at follow-up visit, the number was 1052.
Regular mammography has proven its benefit in the early
detection of CBC.8,17 There are only a few studies to evaluate
the contribution of physical examination in early detection of
CBC. In this study the number of CBCs was enriched to eval-
uate the contribution of physical examination on detecting
CBCs by including all available patients with CBCs of 5589 pa-
tients with a history of breast cancer. The overall detection
rate of CBC by routine physical examination alone is low in
this study, which is consistent with results from a recent
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ing routine physical examination to mammography for the
screening for breast cancer, which reported an additional
5% of tumours detected by physical examination alone.19
There is a trend that the contribution of physical examina-
tion is higher in detecting LRRs in patients after mastectomy,
however, the difference was not statistically significant, prob-
ably due to the small number of LRRs in both groups. Seven
asymptomatic LRRs (30%) in patients after mastectomy were
detected by physical examination alone during routine follow
up. In patients treated with breast conserving surgery, mam-
mography is available and useful for the detection of a LRR
although the sensitivity of mammography will be decreased
in the conserved breast due to the scar and changes in density
of the breast after surgery.20 After mastectomy, the detection
of LRRs was therefore expected to depend more on physical
examination. However, this did not translate into a lower
number of physical examinations performed to detect one
additional LRR after mastectomy due to the lower incidence
of LRR in this group and because these patients often per-
ceived their own recurrences. Overall, the absolute number
of physical examinations to be performed to detect one addi-
tional LRR is therefore still higher after mastectomy than
after breast conserving surgery.
The contribution of physical examination was larger in
detecting CBCs and LRRs among women younger than 60 at
follow-up visit. This finding was in line with that of another
study which evaluated the incremental contribution of phys-
ical examination over mammography in a breast cancer
screening programme.21 Age has been reported to have an
important influence on the sensitivity of mammography
and the value of physical examination. Tumour characteris-
tics are different across ages that might influence the perfor-
mance of routine physical examination.17,19,22 In addition, it is
possible that physicians might pay more attention when they
examine younger patients due to the debatable performance
of mammography. To our knowledge, the age of the patient
has not been taken into account specifically yet during the
follow up of patients with breast cancer. Our results indicate
that more LRRs would be missed in the younger patients than
in older patients if there was no routine physical examination
although the numbers are too small to draw a firm conclu-
sion. If the routine physical examination for patients older
than 60 years of age was no longer performed, there would
be a reduction up to 50% of the number of physical examina-
tions at follow-up visits and 3% CBCs and 17% LRRs would be
later detected. Though there is evidence that early detection
of breast cancer recurrence has beneficial effects on survival,4
there is no convincing evidence that delayed detection of a
LRR or CBC leads to increased mortality. The randomised trial
that would be necessary to prove such an effect on survival is
unlikely to be performed so that these data will not become
available. The possible impact of a reduction of the frequency
of follow-up visits on survival or cost-effectiveness of follow-
up remains unclear and may be the subject of future studies.
The purposes of follow-up of women with breast cancer
are not only early detection of recurrences but also meeting
the needs of patients with respect to psychosocial problems
and side effects, especially in the initial years. Regarding side
effects and psychosocial problems, patient initiated follow-upis an alternative for patients with breast cancer.23,24 Younger
patients with breast cancer are a vulnerable group in terms
of more severe psychosocial effects than older patients.25 It
is unlikely that stopping routine physical examination after
the age of 60 changes the management of side effect and psy-
chosocial problems.
Although the frequency of physical examination was high-
er in the first 5 years after primary treatment, this did not re-
sult in a significant increase of the proportion of tumours
detected by routine physical examination alone. In the first
5 years after primary treatment, follow-up visits were sched-
uled with a decreasing frequency from four times in the 5 year
to once in the fifth year. After 5 years from primary treatment,
follow-up visits were scheduled once a year. Thus more phys-
ical examinations (n = 1041) were done to detect one addi-
tional LRR in the first 5 years than after 5 years since the
primary treatment (n = 521). This could be an argument to re-
duce the number of follow-up visits during the first years after
primary treatment although the goal of these visits is also to
counsel patient and to detect side-effects of the treatment be-
sides the early detection of LRRs and CBCs. The feasibility of
reducing frequency of physical examination in the initial
years after primary treatment deserves further investigation.
The workloads of physical examination for the early detec-
tion of one additional LRR were higher in patients after mas-
tectomy, older patients and in the first 5 years after primary
treatment. The estimates of the number of routine physical
examination undertaken for the early detection of one addi-
tional recurrence are not applicable in detection of CBCs.
The cohort in this study is a CBCs enriched cohort in which
the proportion of CBCs is far higher than that in general co-
hort of patients with a history of breast cancer. As the inci-
dence of CBC was lower than that of LRRs and the
contribution of physical examination was less in detecting
CBC than loco-regional breast cancer as well, we presume,
more physical examinations were needed for one additional
CBC detected than LRRs as shown in this study. It is should
be noted that our findings are only a descriptive cost-effec-
tiveness analysis and more analytical cost-effectiveness and
cost-benefit studies are needed.
In conclusion, 22% of loco-regional recurrences of breast
cancer and 6% of contra-lateral breast cancers would have
been detected later without physical examination. Routine
physical examination probably has the highest contribution
in younger patients (<60). This needs to be confirmed by stud-
ies with larger sample size before an advice can be given on
follow-up regimens. When formulating policy and new guide-
lines of follow-up for patients with breast cancer, patients’
age at follow-up and previous treatment should be taken into
account. The impact of (less frequent) physical examination
on survival deserves further study.Funding
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